Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Teva Pharmaceutical Industries Ltd. (TEVA) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.Teva Pharmaceutical Industries Ltd. is one of 951 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Teva Pharmaceutical Industries Ltd. is currently sporting a Zacks Rank of #2 (Buy).Over the past 90 days, the Zacks Consensus Estimate for TEVA's full-year earnings has moved 0.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.Based on the most recent data, TEVA has returned 11% so far this year. Meanwhile, the Medical sector has returned an average of 1.4% on a year-to-date basis. As we can see, Teva Pharmaceutical Industries Ltd. is performing better than its sector in the calendar year.Another Medical stock, which has outperformed the sector so far this year, is Brainsway Ltd. Sponsored ADR (BWAY). The stock has returned 65.3% year-to-date.In Brainsway Ltd. Sponsored ADR's case, the consensus EPS estimate for the current year increased 15.8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).To break things down more, Teva Pharmaceutical Industries Ltd. belongs to the Medical - Generic Drugs industry, a group that includes 10 individual companies and currently sits at #44 in the Zacks Industry Rank. On average, stocks in this group have gained 12.8% this year, meaning that TEVA is slightly underperforming its industry in terms of year-to-date returns. Brainsway Ltd. Sponsored ADR, however, belongs to the Medical - Products industry. Currently, this 84-stock industry is ranked #161. The industry has moved +0.3% so far this year.Going forward, investors interested in Medical stocks should continue to pay close attention to Teva Pharmaceutical Industries Ltd. and Brainsway Ltd. Sponsored ADR as they could maintain their solid performance.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teva Pharmaceutical Industries Ltd. (TEVA): Free Stock Analysis Report Brainsway Ltd. Sponsored ADR (BWAY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks